A májfunkció romlásának rizikófaktorai sikeres vesetranszplantációt követően = Risk factors for deterioration of liver functions after successful kidney transplantation

Abstract: Introduction: Increase of liver function is one of the most common complications after kidney transplantation due to the use of immunosuppressive therapy and hyperlipidemia in addition to hepatitis C virus (HCV) infection. Method: Following the selection criteria (n = 59), the study is bas...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Borda Bernadett
Nemes Attila
Lengyel Csaba Attila
Várkonyi Tamás
Rárosi Ferenc
Keresztes Csilla
Ottlakán Aurél
Lázár György ifj
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:ORVOSI HETILAP 160 No. 5
doi:10.1556/650.2019.31257

mtmt:30413690
Online Access:http://publicatio.bibl.u-szeged.hu/16076
LEADER 03119nab a2200301 i 4500
001 publ16076
005 20220103153647.0
008 190711s2019 hu o 0|| magyar d
022 |a 0030-6002 
024 7 |a 10.1556/650.2019.31257  |2 doi 
024 7 |a 30413690  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a magyar 
100 1 |a Borda Bernadett 
245 1 2 |a A májfunkció romlásának rizikófaktorai sikeres vesetranszplantációt követően = Risk factors for deterioration of liver functions after successful kidney transplantation  |h [elektronikus dokumentum] /  |c  Borda Bernadett 
260 |c 2019 
300 |a 186-190 
490 0 |a ORVOSI HETILAP  |v 160 No. 5 
520 3 |a Abstract: Introduction: Increase of liver function is one of the most common complications after kidney transplantation due to the use of immunosuppressive therapy and hyperlipidemia in addition to hepatitis C virus (HCV) infection. Method: Following the selection criteria (n = 59), the study is based on applied immunosuppressive therapy, baseline data of patients, further correlation between HCV and liver function deterioration. Patients were subjected to fasting laboratory examination to monitor serum electrolytes, uric acid and albumin levels. We looked at the effects of immunosuppressive therapy on the lipids (TG, TC, HDL, LDL) and liver enzymes (GOT, GPT, ALP, GGT). The analysis of the relationship between lipids and liver enzymes was also included in our study. Results: The data basics were not significantly different between the tacrolimus and the cyclosporine groups. In the laboratory results, Mg levels were significantly different between the two groups (p = 0.044). The impact of HCV on the liver function was significantly different on GGT (p = 0.008). We examed the lipids and liver function level between the tacrolimus and the patients receiving cyclosporine-based immunosuppression and the total cholesterol (p = 0.005) and GOT (p = 0.05) were significantly different between the two groups. Hyperlipidemia was associated with 26% of patients taking tacrolimus-based immunosuppression, and 89% of those receiving cyclosporine; the difference was significant (p = 0.002). Regarding the effect of hyperlipidemia on liver enzymes, ALP (p = 0.006) and GGT (p = 0.0001) were significantly higher. Conclusion: Increases in hepatic enzymes, ALT and GGT indicate the damage to hepatocytes. Beside the increase of liver function, which is the main risk factor in hepatitis on HCV soil, the applied immunosuppressive therapy and hyperlipidemia lead to degradation of allograft function and long-term graft loss. Orv hetil. 2019; 160(5): 186?190. 
700 0 1 |a Nemes Attila  |e aut 
700 0 1 |a Lengyel Csaba Attila  |e aut 
700 0 1 |a Várkonyi Tamás  |e aut 
700 0 1 |a Rárosi Ferenc  |e aut 
700 0 1 |a Keresztes Csilla  |e aut 
700 0 1 |a Ottlakán Aurél  |e aut 
700 0 1 |a Lázár György ifj.  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16076/1/borda_majfunkcio_OH_2019-jan.pdf  |z Dokumentum-elérés  
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16076/2/OH.jpg  |z Dokumentum-elérés